deferasirox has been researched along with Necrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, K; Hirabayashi, Y; Hirota, Y; Ishikawa, E; Ito, M; Ito, T; Katayama, K; Mizoguchi, S; Murata, T; Oda, K; Tanoue, A | 1 |
| Chou, HC; Hsiao, FY; Huang, WF; Tsai, YW | 1 |
| Carrasco, S; Egido, J; Fontecha-Barriuso, M; Gallegos-Villalobos, A; Lopez-Hernandez, FJ; Martin-Sanchez, D; Ortiz, A; Ruiz-Ortega, M; Sanchez-Niño, MD; Sanz, AB | 1 |
3 other study(ies) available for deferasirox and Necrosis
| Article | Year |
|---|---|
Acute kidney injury due to thin basement membrane disease mimicking Deferasirox nephrotoxicity: a case report.
Topics: Acute Kidney Injury; Deferasirox; Diagnosis, Differential; Glomerular Basement Membrane; Hematuria; Humans; Iron Chelating Agents; Kidney Tubules; Male; Middle Aged; Necrosis | 2018 |
Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Benzoates; Chemical and Drug Induced Liver Injury; Deferasirox; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Necrosis; Proportional Hazards Models; Retrospective Studies; Taiwan; Triazoles | 2014 |
Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells.
Topics: Animals; Apoptosis; bcl-X Protein; Benzoates; Caspase 3; Cell Survival; Cytoprotection; Deferasirox; Down-Regulation; Enzyme Activation; Iron; Kidney Tubules, Proximal; Mice; Mitochondria; Models, Biological; Necrosis; Receptor-Interacting Protein Serine-Threonine Kinases; Stress, Physiological; Triazoles | 2017 |